1. Nmnat2 attenuates amyloidogenesis and up-regulates ADAM10 in AMPK activity-dependent manner
- Author
-
Dong-Xiao Duan, Fang-Xiao Shi, Xiang-Shu Cheng, Jun Zhang, Kun-Peng Zhao, Rui Zhu, Xin-Ying Ji, Xin-Wen Zhou, Jin Du, Jian-She Wei, Wang Lin, Yao-Yao Bu, Xiao-Ying Li, Xiao-Hong Li, and Jian-Zhi Wang
- Subjects
AMPK ,Agonist ,Amyloid ,Aging ,medicine.drug_class ,ADAM10 ,AMP-Activated Protein Kinases ,amyloid-β ,Cofactor ,Cell Line ,ADAM10 Protein ,Mice ,medicine ,Animals ,Humans ,Nicotinamide-Nucleotide Adenylyltransferase ,Senile plaques ,biology ,Chemistry ,nicotinamide mononucleotide adenylyltransferase 2 ,Antagonist ,Membrane Proteins ,Cell Biology ,medicine.disease ,Up-Regulation ,Cell biology ,biology.protein ,NAD+ kinase ,Amyloid Precursor Protein Secretases ,Alzheimer disease ,Alzheimer's disease ,Research Paper - Abstract
Amyloid-β (Aβ) accumulating is considered as a causative factor for formation of senile plaque in Alzheimer’s disease (AD), but its mechanism is still elusive. The Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2), a key redox cofactor for energy metabolism, is reduced in AD. Accumulative evidence has shown that the decrease of α-secretase activity, a disintegrin and metalloprotease domain 10 (ADAM10), is responsible for the increase of Aβ productions in AD patient’s brain. Here, we observe that the activity of α-secretase ADAM10 and levels of Nmnat2 are significantly decreased, meanwhile there is a simultaneous elevation of Aβ in Tg2576 mice. Over-expression of Nmnat2 increases the mRNA expression of α-secretase ADAM10 and its activity and inhibits Aβ production in N2a/APPswe cells, which can be abolished by Compound C, an AMPK antagonist, suggesting that AMPK is involved in over-expression of Nmnat2 against Aβ production. The further assays demonstrate that Nmnat2 activates AMPK by up-regulating the ratio of NAD+/NADH, moreover AMPK agonist AICAR can also increase ADAM10 activity and reduces Aβ1-40/1-42. Taken together, Nmnat2 suppresses Aβ production and up-regulates ADAM10 in AMPK activity-dependent manner, suggesting that Nmnat2 may serve as a new potential target in arresting AD.
- Published
- 2021
- Full Text
- View/download PDF